HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Mitsugu Sekimoto Selected Research
Mitsugu Sekimoto Research Topics
Disease
107
Neoplasms (Cancer)
11/2022 - 11/2002
47
Colorectal Neoplasms (Colorectal Cancer)
08/2021 - 06/2002
42
Neoplasm Metastasis (Metastasis)
03/2022 - 06/2002
29
Rectal Neoplasms (Rectal Cancer)
11/2022 - 10/2003
23
Stomach Neoplasms (Stomach Cancer)
12/2021 - 01/2003
16
Lymphatic Metastasis
06/2022 - 06/2002
13
Hepatocellular Carcinoma (Hepatoma)
04/2022 - 05/2003
13
Colonic Neoplasms (Colon Cancer)
01/2018 - 05/2005
10
Adenocarcinoma
03/2022 - 08/2003
8
Carcinoma (Carcinomatosis)
06/2022 - 01/2003
8
Breast Neoplasms (Breast Cancer)
04/2022 - 01/2010
8
Pancreatic Neoplasms (Pancreatic Cancer)
02/2022 - 03/2008
8
Hemorrhage
08/2021 - 11/2003
7
Triple Negative Breast Neoplasms
06/2022 - 01/2020
5
Esophageal Neoplasms (Esophageal Cancer)
04/2021 - 01/2008
5
Diarrhea
01/2021 - 11/2006
5
Venous Thromboembolism
09/2019 - 11/2014
4
Hypoxia (Hypoxemia)
01/2022 - 04/2006
4
Pain (Aches)
01/2022 - 10/2003
4
Neutropenia
05/2016 - 01/2013
3
Postoperative Pain
11/2022 - 10/2013
3
Pathologic Constriction (Stenosis)
11/2022 - 04/2021
3
Inflammation (Inflammations)
06/2022 - 01/2022
3
Cholangiocarcinoma
02/2022 - 04/2010
3
Wounds and Injuries (Trauma)
12/2019 - 11/2003
3
Sigmoid Neoplasms
12/2019 - 11/2010
3
Margins of Excision
10/2019 - 01/2012
3
Nausea
11/2016 - 11/2010
3
Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
11/2016 - 03/2008
3
Thrombosis (Thrombus)
05/2009 - 02/2005
3
Adenoma (Adenomas)
02/2008 - 11/2002
2
Fistula
08/2022 - 11/2011
2
Malnutrition (Nutritional Deficiencies)
02/2022 - 12/2015
Drug/Important Bio-Agent (IBA)
18
Proteins (Proteins, Gene)
FDA Link
04/2022 - 06/2002
16
Irinotecan (Camptosar)
FDA Link
Generic
12/2018 - 10/2004
9
Messenger RNA (mRNA)
IBA
01/2022 - 08/2003
9
Leucovorin (Folinic Acid)
FDA Link
01/2018 - 10/2005
8
Indicators and Reagents (Reagents)
IBA
04/2022 - 01/2004
7
Bevacizumab (Avastin)
FDA Link
09/2021 - 01/2013
7
Oxaliplatin (Eloxatin)
FDA Link
Generic
09/2021 - 08/2005
6
Gemcitabine
FDA Link
02/2022 - 01/2018
6
Fondaparinux (Arixtra)
FDA Link
09/2019 - 11/2014
6
Tegafur
IBA
01/2018 - 01/2006
5
Paclitaxel (Taxol)
FDA Link
Generic
03/2022 - 08/2005
5
Biomarkers (Surrogate Marker)
IBA
02/2022 - 12/2006
5
Cisplatin (Platino)
FDA Link
Generic
01/2022 - 11/2016
5
Uracil
IBA
01/2018 - 01/2006
5
Fluorouracil (Carac)
FDA Link
Generic
01/2018 - 10/2005
5
Biological Products
IBA
07/2012 - 01/2003
4
RNA (Ribonucleic Acid)
IBA
09/2022 - 02/2004
4
Trastuzumab (Herceptin)
FDA Link
12/2018 - 11/2014
3
Anti-Bacterial Agents (Antibiotics)
IBA
06/2022 - 11/2014
3
Perilipin-2
IBA
04/2022 - 01/2020
3
Fatty Acids (Saturated Fatty Acids)
IBA
04/2022 - 02/2010
3
130-nm albumin-bound paclitaxel
IBA
02/2022 - 01/2018
3
B7-H1 Antigen
IBA
03/2021 - 01/2021
3
Capecitabine (Xeloda)
FDA Link
12/2019 - 02/2008
3
Anticoagulants
IBA
09/2019 - 02/2005
3
Carcinoembryonic Antigen
IBA
01/2016 - 06/2002
3
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
02/2011 - 02/2004
3
Calcibiotic Root Canal Sealer
IBA
11/2010 - 02/2008
3
Complementary DNA (cDNA)
IBA
12/2008 - 01/2007
3
Cyclin D1
IBA
08/2006 - 11/2002
2
Ligands
IBA
06/2022 - 04/2022
2
Immune Checkpoint Inhibitors
IBA
06/2022 - 09/2021
2
Albumins
IBA
04/2022 - 02/2022
2
Bilirubin
IBA
04/2022 - 11/2011
2
lenvatinib
IBA
04/2022 - 12/2021
2
Adenosine Diphosphate (ADP)
IBA
04/2022 - 04/2022
2
Immunologic Factors (Immunomodulators)
IBA
02/2022 - 11/2021
2
Active Hexose Correlated Compound
IBA
02/2022 - 11/2021
2
Carbohydrates
IBA
02/2022 - 05/2012
2
Sorafenib (BAY 43-9006)
FDA Link
01/2022 - 04/2021
2
Carbon
IBA
01/2022 - 11/2010
2
Pharmaceutical Preparations
IBA
01/2022 - 11/2016
Therapy/Procedure
47
Therapeutics
09/2022 - 10/2002
43
Drug Therapy (Chemotherapy)
06/2022 - 08/2006
16
Gastrectomy
08/2021 - 01/2003
15
Adjuvant Chemotherapy
06/2022 - 10/2004
14
Neoadjuvant Therapy
02/2022 - 01/2011
13
Lymph Node Excision (Lymph Node Dissection)
11/2021 - 01/2003
10
Radiotherapy
01/2022 - 11/2006
7
Pancreatectomy
02/2022 - 11/2015
7
Combination Drug Therapy (Combination Chemotherapy)
01/2022 - 10/2004
6
Pancreaticoduodenectomy
11/2022 - 11/2015
6
Hepatectomy
02/2021 - 12/2010
5
Laparotomy
03/2022 - 09/2014
4
Aftercare (After-Treatment)
06/2022 - 11/2014
4
Colectomy
03/2022 - 04/2014
4
Combined Modality Therapy
02/2022 - 11/2015
4
Pelvic Exenteration
01/2022 - 11/2011
4
Operative Surgical Procedures
08/2021 - 01/2017
4
Proctectomy
11/2017 - 10/2003
3
Immunotherapy
06/2022 - 02/2010
3
Chemoradiotherapy
02/2022 - 11/2016
3
Heavy Ion Radiotherapy
01/2022 - 01/2016
3
Segmental Mastectomy (Lumpectomy)
03/2020 - 11/2016
3
Oral Administration
12/2018 - 03/2010
3
Restorative Proctocolectomy
11/2016 - 03/2008
3
Splenectomy
05/2009 - 02/2005